case of secondary alkyl zinc reagents.14 Our preliminary
studies showed that addition of N-methylimidazole also
suppresses this undesired transformation leading to branched
products 13ꢀ14 in excellent yields without detectable forma-
tion of isomerized byproducts (Scheme 4).15
Scheme 3. Sequence Leading to the Desired “Product” When
Pd(0)Ln = PdCl2(Amphos)2/N-Methylimidazole, or Product
Mixtures Using Other Catalysts/Additives
Scheme 4. Cross-Couplings of Aryl Halides with sec-C4H9ZnIa
a Conditions: organozinc halide (1.1 mmol, 1.0 M in THF), aryl
bromide (1.0 mmol), Pd(Amphos)2 (2 mol %), N-MeIm (2.0 mmol), 6 h
at 40 °C for 13 and 3 h at rt for 14. Isolated yields.
In summary, a new catalyst system has been identified
thatoffersa generalsolution tofundamental problems that
can be encountered in Negishi couplings: that is, protio-
quenching and homocoupling that can dramatically im-
pact yields and stereochemical issues, most notably when
Z-alkenyl educts are involved. These “Negishi-Plus” reac-
tions involve a combination of catalytic PdCl2(Amphos)2
together with stoichiometric N-methylimidazole; when
used in THF at room temperature, cross-couplings be-
tween 1° and 2° alkylzinc reagents and variously substi-
tuted alkenyl iodides or bromides take place in high yields.
scrambling. We assume that addition of stoichimetric
amounts of N-methylimidazole, or TMEDA, serves the same
purpose, thus allowing use of simple monodentate ligand-
containing catalysts such as PdCl2(Amphos)2. Presumably,
the presence of these additives in stoichiometric amounts
provides a coordinating ligand for both catalytic palla-
dium12 and stoichiometric zinc.13
Acknowledgment. Financial support provided by the
NIH is warmly acknowledged. We are grateful to Johnson
Matthey for generously supplying PdCl2(Amphos)2 and
Pd(Amphos)2, and to Boulder Scientific for the Cp2ZrCl2
used to make the alkenyl halides used in this study.
It is known that β-H elimination is also responsible for
the formation of isomerized cross-coupled products in the
(12) (a) Szulmanowicz, M. S.; Zawartka, W.; Gniewek, A.; Trzeciak,
A. M. Inorg. Chim. Acta 2010, 363, 4346. (b) Mathews, C. J.; Smith, P. J.;
Welton, T. J. Mol. Catal. A: Chem. 2003, 206, 77.
Supporting Information Available. Experimental pro-
cedures and product spectral data are provided. This
material is available free of charge via the Internet at
(13) (a) Ross, A. J.; Dreiocker, F.; Schaefer, M.; Oomens, J.; Meijer,
A. J. H. M.; Pickup, B. T.; Jackson, R. F. W. J. Org. Chem. 2011, 76,
1727. (b) Sen Gupta, P. K.; Houk, L. W.; van der Helm, D.; Hossain,
M. B. Acta Crystallogr. 1982, B38, 1818. (c) Citeau, H.; Conrad, O.;
Gulando, D. M. Acta Crystallogr. 2001, E57, m5. (d) Htoon, C.; Ladd,
M. F. C. J. Cryst. Mol. Struct. 1974, 4, 357. (e) Yasuda, H.; Ohnuma, Y.;
Nakamura, A.; Kai, Y.; Yasuoka, N.; Kasai, N. Bull. Chem. Soc. Jpn.
1980, 53, 1101. (f) Andrews, P. C.; Raston, C. L.; Skelton, B. W.; White,
A. H. Organometallics 1998, 17, 779.
(14) (a) Han, C.; Buchwald, S. L. J. Am. Chem. Soc. 2009, 131, 7532.
(b) Kondolff, I.; Doucet, H.; Santalli, M. Organomet. 2006, 25, 5219.
(c) C-alimsiz, S.; Organ, M. G. Chem. Commun. 2011, 47, 5181.
(15) Use of Pd(Amphos)2 instead of PdCl2(Amphos)2 in this case was
nessesary to achieve full conversion.
Org. Lett., Vol. 13, No. 15, 2011
3825